Zymosan priming protects rats against pulmonary oxygen toxicity

Inflammation Research

Volumn 55, Issue 12, 2006, Pages 565-571

  Berg, J T ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b Lung Injury Research Institute   (Philippines)

Author keywords

Acute lung injury; Animal models; Endotoxin; Hyperoxia; Zymosan

Indexed keywords

PLASMA PROTEIN; SODIUM CHLORIDE; ZYMOSAN; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPOSURE; HYPEROXIA; LOW DRUG DOSE; LUNG INJURY; LUNG TOXICITY; LUNG WEIGHT; NONHUMAN; OXYGEN TENSION; OXYGEN TOXICITY; PLEURA EFFUSION; RAT; SINGLE DRUG DOSE; ANIMAL; LUNG; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; HYPEROXIA; LUNG; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; ZYMOSAN;

EID: 33846387053     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-006-6047-5     Document Type: Article

References (26)

1. Young S-H, Ye J, Frazer DG, Shi X, Castranova V. Molecular mechanism of tumor necrosis factor- production in 1→3-β-glucan (zymosan)-activated macrophages. J Biol Chem 2001; 276: 20781-7.
2. Robertshaw HJ, Brennan FM. Release of tumor necrosis factor (TNF) by TNF cleaving enzyme (TACE) in response to septic stimuli in vitro. Br J Anaesth 2005; 94: 222-8.
3. Shirahama M, Ishibashi H, Tsuchiya Y, Kurokawa S, Okumura Y, Niho Y. Kinetics and parameters of the induction of interleukin 1 secretion by rat Kupffer cells. J Clin Lab Immunol 1988; 27: 127-32.
4. Lepe-Zuniga JL, Gery I. Production of intra- and extracellular interleukin-1 (IL-1) by human monocytes. Clin Immunol Immunopathol 1984; 31: 222-30.
5. Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem 1990; 192: 245-61.
6. White CW, Ghezzi P, Dinarello CA, Caldwell SA, McMurtry IF, Repine JE. Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia. J Clin Invest 1987; 79: 1868-73.
7. Tsan M-F, White JE, Santana TA, Lee CY. Tracheal insufflation of tumor necrosis factor protects rats against oxygen toxicity. J Appl Physiol 1990; 68: 1211-9.
8. Tsan M-F, Lee CY, White JE. Interleukin 1 protects rats against oxygen toxicity. J Appl Physiol 1991; 71: 688-97.
9. Berg JT, Allison RC, Prasad VR, Taylor AE. Endotoxin protection of rats against pulmonary oxygen toxicity: possible cytokine involvement. J Appl Physiol 1990; 68: 549-53.
10. Cuzzocrea S, Costantino G, Mazzon E, De Sorro A, Caputi AP. Beneficial effects of Mn(III)tetrakis (4-benzoic acid) porphyrin (MnTBAP), a superoxide mimetic, in zymosan-induced shock. Br J Pharmacol 1999; 128: 1241-51.
11. Damas J, Remacle-Volon G, Bourdon V. Platelet-activating factor and the vascular effects of zymosan in rats. Eur J Pharmacol 1993; 231: 231-6.
12. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Nat Acad Sci USA 1975; 72: 3666-70.
13. Dinarello CA. Interleukin-1. Rev Infect Dis 1984; 6: 51-95.
14. Uchiba M, Okajima K, Murakami K. Endotoxin-induced pulmonary vascular injury is mainly mediated by activated neutrophils in rats. Thromb Res 1995; 78: 117-25.
15. Cuzzocrea S, Mazzon E, Di Paola R, Genovese T, Serraino, Dugo L et al. Protective effects of M40401, a selective superoxide dismutase mimetic, on zymosan-induced nonseptic shock. Crit Care Med 2004; 32: 157-67.
16. Addison PD, Berry LJ. Passive protection against x-irradiation with serum from zymosan-primed and endotoxin-injected mice. J Reticulo Soc 1981; 30: 301-11.
17. Moore RN, Goodrum KJ, Couch RE Jr, Berry LJ. Elicitation of endotoxemic effects in C3H/HeJ mice with glucocorticoid antagonizing factor and partial characterization of the factor. Infect Immun 1978; 19: 79-86.
18. Berg, JT, Allison RC, Taylor, AE. Endotoxin extends survival of adult mice in hyperoxia. Proc Exp Biol Med 1990; 193: 167-70.
19. Smith RM. Pulmonary oxygen toxicity in rats: prevention by pyrogenic diphosphoryl lipid a and potentiation by nontoxic monophosphoryl lipid a and lipid x. Res Commun Chem Path Pharm 1988; 62: 221-34.
20. Fujita Y, Mori I, Kitano S. Color reaction between pyrogallol red-molybdenum (VI) complex and protein. Bunseki Kagaku 1983; 32: E379-E386.
21. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A et al. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163: 1433-50.
22. Bernaudin JF, Theven D, Pinchon MC, Brun-Pascaud M, Bellon B, Pocidalo JJ. Protein transfer in hyperoxic induced pleural effusion in the rat. Exp Lung Res 1986; 10: 23-38.
23. Wiener-Kronish JP, Broaddus VC, Albertine KH, Gropper MA, Matthay MA, Staub NC. Relationship of pleural effusions to increased permeability pulmonary edema in anesthetized sheep. J Clin Invest 1988; 82: 1422-9.
24. Frank L, Yam J, Roberts RJ. The role of endotoxin in protection of adult rats from oxygen-induced lung toxicity. J Clin Invest 1978; 61: 269-75.
25. Jensen JC, Pogrebniak HW, Pass HI, Buresh C, Merino MJ, Kauffman D et al. Role of tumor necrosis factor in oxygen toxicity. J Appl Physiol 1992; 72: 1902-7.
26. Tsan MF, White JE, Michelsen PB, Wong GH. Pulmonary O2 Toxicity: role of endogenous tumor necrosis factor. Exp Lung Res 1995; 21: 589-97.